Pharmagreen Biotech Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Pharmagreen Biotech Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to 2022.
  • Pharmagreen Biotech Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$163K, a 165% decline year-over-year.
  • Pharmagreen Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$876K, a 80.7% increase from 2021.
  • Pharmagreen Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$4.53M, a 82.6% decline from 2020.
  • Pharmagreen Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$2.48M, a 223% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$876K +$3.66M +80.7% Oct 1, 2021 Sep 30, 2022 10-K 2023-01-17
2021 -$4.53M -$2.05M -82.6% Oct 1, 2020 Sep 30, 2021 10-K 2023-01-17
2020 -$2.48M -$1.72M -223% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-29
2019 -$768K +$306K +28.5% Oct 1, 2018 Sep 30, 2019 10-K 2021-01-08
2018 -$1.07M Oct 1, 2017 Sep 30, 2018 10-K 2019-12-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.